Charter Trust Company Cut Colgate Palmolive Co (CL) Position; Shorts at MAYNE PHARMA GROUP LTD ORDINARY SHARES (MAYNF) Lowered By 4.36%

Mayne Pharma Group Limited (OTCMKTS:MAYNF) Logo

Charter Trust Company decreased Colgate Palmolive Co (CL) stake by 47.87% reported in 2018Q1 SEC filing. Charter Trust Company sold 173,118 shares as Colgate Palmolive Co (CL)’s stock declined 10.30%. The Charter Trust Company holds 188,536 shares with $13.52 million value, down from 361,654 last quarter. Colgate Palmolive Co now has $57.05B valuation. The stock increased 0.40% or $0.26 during the last trading session, reaching $65.4. About 592,331 shares traded. Colgate-Palmolive Company (NYSE:CL) has declined 15.42% since June 27, 2017 and is downtrending. It has underperformed by 27.99% the S&P500. Some Historical CL News: 21/05/2018 – COLGATE INDIA 4Q REV. 10.9B RUPEES; 12/04/2018 – Colgate-Palmolive Earns 2018 ENERGY STAR® Partner of the Year Award for the Eighth Consecutive Year; 21/05/2018 – COLGATE-PALMOLIVE (INDIA) LTD COLG.NS – CONSENSUS FORECAST FOR MARCH QTR PROFIT WAS 1.84 BLN RUPEES; 22/05/2018 – P&G, Colgate and Clorox were last this cheap on a relative basis to the market seven to nine years ago; 19/03/2018 – COLGATE CONTINUES TO RECOMMEND HOLDERS REJECT “MINI-TENDER”; 23/05/2018 – CL COMMITS TO 100% RECYCLABLE PLASTICS IN PACKAGING BY 2025; 07/03/2018 – Colgate-Palmolive Raises Dividend to 42c Vs. 40c; 27/04/2018 – COLGATE-PALMOLIVE – CONTINUE TO PLAN FOR INCREASED ADVERTISING INVESTMENT FOR FULL YEAR IN SUPPORT OF NEW PRODUCTS; 27/04/2018 – Colgate-Palmolive 1Q Pricing Flat; 30/04/2018 – Colgate-Palmolive Webcasts Presentation at its 2018 Annual Meeting of Stockholders May 11, 2018 – 10:00 a.m. ET

MAYNE PHARMA GROUP LTD ORDINARY SHARES (OTCMKTS:MAYNF) had a decrease of 4.36% in short interest. MAYNF’s SI was 3.10 million shares in June as released by FINRA. Its down 4.36% from 3.25M shares previously. With 1,800 avg volume, 1724 days are for MAYNE PHARMA GROUP LTD ORDINARY SHARES (OTCMKTS:MAYNF)’s short sellers to cover MAYNF’s short positions. The SI to MAYNE PHARMA GROUP LTD ORDINARY SHARES’s float is 0.24%. It closed at $0.63 lastly. It is down 0.00% since June 27, 2017 and is . It has underperformed by 12.57% the S&P500.

Mayne Pharma Group Limited manufactures and sells branded and generic pharmaceutical products worldwide. The company has market cap of $1.01 billion. It operates through four divisions: Generic Products, Specialty Brands, Metrics Contract Services, and Mayne Pharma International. It currently has negative earnings. The firm provides pharmaceuticals in the forms of tablets, capsules, foams, creams, powders, patches, pastes, and gels.

Among 27 analysts covering Colgate-Palmolive (NYSE:CL), 6 have Buy rating, 1 Sell and 20 Hold. Therefore 22% are positive. Colgate-Palmolive has $88 highest and $65 lowest target. $72.48’s average target is 10.83% above currents $65.4 stock price. Colgate-Palmolive had 73 analyst reports since July 21, 2015 according to SRatingsIntel. Macquarie Research upgraded Colgate-Palmolive Company (NYSE:CL) on Tuesday, December 19 to “Outperform” rating. Jefferies maintained Colgate-Palmolive Company (NYSE:CL) on Monday, October 30 with “Hold” rating. The company was downgraded on Wednesday, November 29 by Societe Generale. Sterne Agee CRT downgraded the stock to “Neutral” rating in Friday, February 26 report. UBS maintained Colgate-Palmolive Company (NYSE:CL) rating on Friday, October 28. UBS has “Neutral” rating and $76 target. The stock of Colgate-Palmolive Company (NYSE:CL) has “Hold” rating given on Tuesday, September 5 by RBC Capital Markets. Atlantic Securities initiated the shares of CL in report on Wednesday, January 6 with “Overweight” rating. The firm has “Neutral” rating given on Tuesday, January 30 by Citigroup. The rating was initiated by KeyBanc Capital Markets on Friday, September 9 with “Sector Weight”. The firm earned “Hold” rating on Friday, July 21 by Jefferies.

Analysts await Colgate-Palmolive Company (NYSE:CL) to report earnings on July, 20. They expect $0.79 EPS, up 9.72% or $0.07 from last year’s $0.72 per share. CL’s profit will be $689.14 million for 20.70 P/E if the $0.79 EPS becomes a reality. After $0.74 actual EPS reported by Colgate-Palmolive Company for the previous quarter, Wall Street now forecasts 6.76% EPS growth.

Since January 9, 2018, it had 0 buys, and 25 insider sales for $44.07 million activity. HICKEY DENNIS J had sold 5,651 shares worth $396,561 on Tuesday, February 20. On Wednesday, January 31 Wallace Noel R. sold $9.32M worth of Colgate-Palmolive Company (NYSE:CL) or 126,304 shares. Gayle Helene D had sold 7,000 shares worth $435,600 on Thursday, May 10. $1.40 million worth of Colgate-Palmolive Company (NYSE:CL) was sold by Marsili Daniel B on Monday, April 16. $68,390 worth of stock was sold by Daniels Jennifer on Tuesday, January 9. Another trade for 4,161 shares valued at $292,026 was made by Skala Justin on Tuesday, February 20. Dolan Victoria L also sold $120,830 worth of Colgate-Palmolive Company (NYSE:CL) shares.

Another recent and important Colgate-Palmolive Company (NYSE:CL) news was published by Seekingalpha.com which published an article titled: “Analysts show little appetite for Kraft Heinz takeover of Campbell Soup” on June 26, 2018.

Colgate-Palmolive Company (NYSE:CL) Institutional Positions Chart